Post

INV-347 by Inversago Pharma for Obesity: Likelihood of Approval

INV-347 is under clinical development by Inversago Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I …

PF-07872412 by Pfizer for Streptococcal Pneumonia: Likelihood of Approval

PF-07872412 is under clinical development by Pfizer and currently in Phase I for Streptococcal Pneumonia. According to GlobalData, Phase I …

Ketamine by NRX Pharmaceuticals for Bipolar Disorder (Manic Depression): Likelihood of Approval

Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression). According to …

NA-921 by Biomed Industries for Rett Syndrome: Likelihood of Approval

NA-921 is under clinical development by Biomed Industries and currently in Phase III for Rett Syndrome. According to GlobalData, Phase …

NA-921 by Biomed Industries for Fragile X Syndrome: Likelihood of Approval

NA-921 is under clinical development by Biomed Industries and currently in Phase III for Fragile X Syndrome. According to GlobalData, …